Sun Life invested an undisclosed sum as part of the series A round, disclosed alongside news Bowtie has received a licence to sell life insurance virtually.

Novo will take two board seats at newly-founded startup Aristea Therapeutics after a $15m investment to fund a pipeline of inflammatory disease drugs.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

MRL Ventures Fund and Roche Fund have taken part in the intracellular drug developer's series A, which is commercialising research by Prof Dehua Pei at OSU.

MRL Ventures Fund and Roche Fund have taken part in the intracellular drug developer's series A round, which will fund clinical trials of its lead program.

Cambridge textile dyeing spinout Colorifix has been backed by Cambridge Enterprise and retailer H&M in its first disclosed equity round.

The smart home subsidiary of China-based Haier Group has completed a series A round led by China International Capital Corporation.

Boston Scientific was among the participants in the urological cancer device developer's first funding round, as it prepares for US trials late next year.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Spun out of UC Berkeley research, Magnetic Insight is commercialising an in vivo molecular imaging technology that operates by applying magnetic fields to iron oxide tracers.